Australia to Start Vaccinating Young Children From Early 2022
(Bloomberg) -- Australia will begin vaccinating young children starting early next year once authorities receive final approvals in the coming weeks.Â
Australia's pharmaceutical regulator, the Therapeutic Goods Administration, has provisionally approved a one-third dose of Pfizer's vaccine for children aged 5-11 years, Health Minister Greg Hunt said in a statement Sunday. Subject to final approvals, the authorities will begin vaccinations starting Jan. 10, he said.Â
Final recommendations from the Australian Technical Advisory Group on Immunisation are expected in the coming weeks, and the program will be timed to provide at least one dose to the kids ahead of the new school year in 2022, Hunt said.Â
After a slow start, Australia ramped up its vaccination program in the second half of 2021 to end months-long lockdowns of the nation's two most populous cities as they combated a surge driven by the delta variant. About 93% of Australians aged 16 and over have had at least one dose of the vaccine, while about 77% of those aged 12-15 have had their first shot, Hunt said.Â
Australia has a deal in place to receive enough of Pfizer's pediatric vaccine for the entire cohort, with the first shipment expected in early January, he said.Â
Read More: Melbourne Reopens, Ending One of World's Longest LockdownsÂ
©2021 Bloomberg L.P.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.